BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 34145241)

  • 1. Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease.
    Lacy M; Bürger C; Shami A; Ahmadsei M; Winkels H; Nitz K; van Tiel CM; Seijkens TTP; Kusters PJH; Karshovka E; Prange KHM; Wu Y; Brouns SLN; Unterlugauer S; Kuijpers MJE; Reiche ME; Steffens S; Edsfeldt A; Megens RTA; Heemskerk JWM; Goncalves I; Weber C; Gerdes N; Atzler D; Lutgens E
    Nat Commun; 2021 Jun; 12(1):3754. PubMed ID: 34145241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet CD40L Modulates Thrombus Growth Via Phosphatidylinositol 3-Kinase β, and Not Via CD40 and IκB Kinase α.
    Kuijpers MJ; Mattheij NJ; Cipolla L; van Geffen JP; Lawrence T; Donners MM; Boon L; Lievens D; Torti M; Noels H; Gerdes N; Cosemans JM; Lutgens E; Heemskerk JW
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1374-81. PubMed ID: 25908768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis.
    Lievens D; Eijgelaar WJ; Biessen EA; Daemen MJ; Lutgens E
    Thromb Haemost; 2009 Aug; 102(2):206-14. PubMed ID: 19652870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis.
    Büchner K; Henn V; Gräfe M; de Boer OJ; Becker AE; Kroczek RA
    J Pathol; 2003 Oct; 201(2):288-95. PubMed ID: 14517846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis.
    Mach F; Schönbeck U; Sukhova GK; Bourcier T; Bonnefoy JY; Pober JS; Libby P
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1931-6. PubMed ID: 9050882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 signaling in vascular cells: a key role in atherosclerosis?
    Mach F; Schönbeck U; Libby P
    Atherosclerosis; 1998 Apr; 137 Suppl():S89-95. PubMed ID: 9694547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40L Priming of Platelets via NF-κB Activation is CD40- and TAK1-Dependent.
    Kojok K; Akoum SE; Mohsen M; Mourad W; Merhi Y
    J Am Heart Assoc; 2018 Dec; 7(23):e03677. PubMed ID: 30571597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes.
    Gerdes N; Seijkens T; Lievens D; Kuijpers MJ; Winkels H; Projahn D; Hartwig H; Beckers L; Megens RT; Boon L; Noelle RJ; Soehnlein O; Heemskerk JW; Weber C; Lutgens E
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):482-90. PubMed ID: 26821950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.
    Danese S; Sans M; Scaldaferri F; Sgambato A; Rutella S; Cittadini A; Piqué JM; Panes J; Katz JA; Gasbarrini A; Fiocchi C
    J Immunol; 2006 Feb; 176(4):2617-24. PubMed ID: 16456024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile.
    Lutgens E; Lievens D; Beckers L; Wijnands E; Soehnlein O; Zernecke A; Seijkens T; Engel D; Cleutjens J; Keller AM; Naik SH; Boon L; Oufella HA; Mallat Z; Ahonen CL; Noelle RJ; de Winther MP; Daemen MJ; Biessen EA; Weber C
    J Exp Med; 2010 Feb; 207(2):391-404. PubMed ID: 20100871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD40-CD40L system in cardiovascular disease.
    Pamukcu B; Lip GY; Snezhitskiy V; Shantsila E
    Ann Med; 2011 Aug; 43(5):331-40. PubMed ID: 21244217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-stimulators CD40-CD40L, a potential immune-therapy target for atherosclerosis: A review.
    Tian S; Wang Y; Wan J; Yang M; Fu Z
    Medicine (Baltimore); 2024 Apr; 103(14):e37718. PubMed ID: 38579073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine Fibroblastic Reticular Cells From Lymph Node Interact With CD4+ T Cells Through CD40-CD40L.
    Nakayama Y; Brinkman CC; Bromberg JS
    Transplantation; 2015 Aug; 99(8):1561-7. PubMed ID: 25856408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation.
    Stokes KY; Calahan L; Hamric CM; Russell JM; Granger DN
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H689-97. PubMed ID: 19112095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells.
    Schönbeck U; Gerdes N; Varo N; Reynolds RS; Horton DB; Bavendiek U; Robbie L; Ganz P; Kinlay S; Libby P
    Circulation; 2002 Dec; 106(23):2888-93. PubMed ID: 12460867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ T lymphocytes expressing CD40 ligand help the IgM antibody response to soluble pneumococcal polysaccharides via an intermediate cell type.
    Jeurissen A; Billiau AD; Moens L; Shengqiao L; Landuyt W; Wuyts G; Boon L; Waer M; Ceuppens JL; Bossuyt X
    J Immunol; 2006 Jan; 176(1):529-36. PubMed ID: 16365447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.
    Oxenius A; Campbell KA; Maliszewski CR; Kishimoto T; Kikutani H; Hengartner H; Zinkernagel RM; Bachmann MF
    J Exp Med; 1996 May; 183(5):2209-18. PubMed ID: 8642330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential requirements of T cell subsets for CD40 costimulation in immunity to Blastomyces dermatitidis.
    Wüthrich M; Fisette PL; Filutowicz HI; Klein BS
    J Immunol; 2006 May; 176(9):5538-47. PubMed ID: 16622023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L.
    Price JD; Beauchamp NM; Rahir G; Zhao Y; Rieger CC; Lau-Kilby AW; Tarbell KV
    J Leukoc Biol; 2014 Feb; 95(2):325-36. PubMed ID: 24082013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD40-CD40L interactions in atherosclerosis.
    Lutgens E; Daemen MJ
    Trends Cardiovasc Med; 2002 Jan; 12(1):27-32. PubMed ID: 11796241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.